September 17, 2014 1:20 PM ET

Pharmaceuticals

Company Overview of Conforma Therapeutics Corporation

Company Overview

Conforma Therapeutics Corporation designs and develops drugs for the treatment of cancer. It develops drugs that induce tumor cells to degrade the proteins that promote cancer growth. The company offers the HSP90 product, CNF1010, which is used for the treatment of cancer. The company was incorporated in 1999 and is based in San Diego, California. As per the transaction announced on May 2, 2006, Conforma Therapeutics Corporation operates as a subsidiary of Biogen Idec Inc.

9393 Towne Centre Drive

Suite 240

San Diego, CA 92121

United States

Founded in 1999

Phone:

858-657-0300

Fax:

858-657-0343

Key Executives for Conforma Therapeutics Corporation

Vice President of Preclinical Development
Vice President of Medicinal Chemistry
Age: 54
Vice President of Biology
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Mithridion, Inc. United States
Ranbaxy Inc. United States
Optimer Pharmaceuticals, Inc. United States
OncoSource Rx, LLC United States
Physician Choice, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Conforma Therapeutics Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.